Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC)
Publication
, Conference
Slovin, SF; Knudsen, KE; Halabi, S; Fleming, MT; Molina, AM; Wolf, SP; de Leeuw, R; Fernandez, C; Kang, P; Southwell, T; Jones, CL; Kelly, WK ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
February 20, 2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 20, 2020
Volume
38
Issue
6
Location
San Francisco, CA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Slovin, S. F., Knudsen, K. E., Halabi, S., Fleming, M. T., Molina, A. M., Wolf, S. P., … Kelly, W. K. (2020). Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY.
Slovin, Susan F., Karen E. Knudsen, Susan Halabi, Mark T. Fleming, Ana M. Molina, Steven Paul Wolf, Renee de Leeuw, et al. “Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.
Slovin SF, Knudsen KE, Halabi S, Fleming MT, Molina AM, Wolf SP, et al. Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC). In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.
Slovin, Susan F., et al. “Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 6, AMER SOC CLINICAL ONCOLOGY, 2020.
Slovin SF, Knudsen KE, Halabi S, Fleming MT, Molina AM, Wolf SP, de Leeuw R, Fernandez C, Kang P, Southwell T, Jones CL, Fernandez E, Kelly WK. Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 20, 2020
Volume
38
Issue
6
Location
San Francisco, CA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences